About the Company
The Flowserve Corporation is an American multinational corporation and one of the largest suppliers of industrial and environmental machinery such as pumps, valves, end face mechanical seals, automation, and services to the power, oil, gas, chemical and other industries. Headquartered in Irving, Texas, which is in the Dallas–Fort Worth Metroplex, Flowserve employs close to 16,000 employees in more than 50 countries. Flowserve sells products and offers aftermarket services to engineering and construction firms, original equipment manufacturers, distributors, and end users. The Flowserve brand name originated in 1997 with a merger of BW/IP (Borg-Warner/IP International) and Durco International. On August 21, 2007, Flowserve Corporation was recognized by CIO magazine as one of the 2007 CIO 100 Award Honorees.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $PMVP News
PMV Pharmaceuticals, Inc. (PMVP)
20, 2023 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumo The average of price targets ...
PMV Pharmaceuticals, Inc. (PMVP) Loses -70.19% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
PMV Pharmaceuticals, Inc. (PMVP) has been beaten down lately with too much selling pressure. While the stock has lost 70.2% over the past four weeks, there is light at the end of the tunnel as it ...
PMV Pharma Stock (NASDAQ:PMVP), Quotes and News Summary
Inc. Lisa Levin Precision Oncology PMV Pharmaceuticals Reveals Early Data From Cancer Study In Pretreated Patients PMV Pharmaceuticals Inc (NASDAQ: PMVP) announced updated Phase 1 results from ...
PMV Pharmaceuticals Inc (PMVP) Shares Rise Despite Market Challenges
The stock of PMV Pharmaceuticals Inc (NASDAQ: PMVP) has increased by 7.91 when compared to last closing price of 1.58.Despite this, the company has seen a gain of 6.56% in its stock price over the ...
PMV Pharmaceuticals: Buy Rating Affirmed Amid Strong Financials and Promising Clinical Prospects
PMV Pharmaceuticals (PMVP) Company Description: PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic ...
PMV Pharmaceuticals Reports Full Year 2023 Financial Results and Corporate Highlights
PRINCETON, N.J., Feb. 29, 2024 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic ...
PMVP PMV Pharmaceuticals, Inc.
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It’s lead product ...
PMV Pharmaceuticals Inc Ordinary Shares PMVP
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
PMV Pharmaceuticals, Inc. (PMVP)
Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...
PMV Pharmaceuticals Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Pmv Pharmaceuticals Inc (PMVP)
PMV Pharmaceuticals, Inc. (PMVP) reported Q4 EPS of ($1.61), $1.17 worse than the analyst estimate of ($0.44).
Loading the latest forecasts...